Corresponding anaplastic lymphoma kinase-tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus

Rutger C Melchers; Rein Willemze; Remco van Doorn; Patty M Jansen; Arjen H G Cleven; Nienke Solleveld; Maarten H Vermeer; Koen D Quint

doi:10.1016/j.jdcr.2019.09.021

Corresponding anaplastic lymphoma kinase-tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus

JAAD Case Rep. 2019 Oct 24;5(11):970-972. doi: 10.1016/j.jdcr.2019.09.021. eCollection 2019 Nov.

Authors

Rutger C Melchers¹, Rein Willemze¹, Remco van Doorn¹, Patty M Jansen², Arjen H G Cleven², Nienke Solleveld², Maarten H Vermeer¹, Koen D Quint¹

Affiliations

¹ Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

No abstract available

Keywords: ALK; ALK, anaplastic lymphoma kinase; C-ALCL; C-ALCL, cutaneous anaplastic large T-cell lymphoma; CD30; Spitz; Spitz nevus; Spitz tumor; TPM3; TPM3, tropomyosin 3; TPM3-ALK; anaplastic lymphoma kinase; concurrent; corresponding; fusion; primary cutaneous anaplastic large cell lymphoma; rearrangement; translocation; tropomyosin 3.

Publication types

Case Reports